Statin-eligible group | n (%) |
---|---|
per 2013 ACC/AHA guidelines | |
Aged ≥21 y with ASCVD | 197 (4.5) |
Aged ≥21 y with untreated LDL-C ≥190 mg/dL | 136 (3.1) |
Aged 40–75 y with LDL-C 70–189 mg/dL and DM without ASCVD | 510 (11.6) |
Aged 40–75 y with LDL-C 70–189 mg/dL without ASCVD or DM and ASCVD risk ≥7.5% | 852 (19.5) |
Total eligible | 1695 (39.0) |
per 2002 NCEP ATP III guidelines | |
0–1 risk factor and LDL-C ≥190 mg/dL | 104 (2.4) |
≥ 2 risk factors and LDL-C ≥130 mg/dL | 566 (12.9) |
CHD, TIA, stroke, PAD, DM, and LDL-C ≥100 mg/dL | 373 (8.5) |
Total eligible | 1043 (24.0) |